Life Sciences

Life Sciences Law360 provides breaking legal news and analysis on the pharmaceutical and medical device industry. Coverage includes high-stakes litigation and policy developments that affect life sciences companies, as well as licensing deals, mergers, and other corporate transactions.



Sign up for a 7-day FREE trial today!



Latest News in Life Sciences

  • November 13, 2026

    Ex-Cravath Staffer In Plea Talks After Insider Trading Charge

    A former Cravath Swaine & Moore LLP document processing specialist who has been charged with insider trading is eyeing a possible plea deal, according to a New York federal court filing docketed Friday. 

  • November 13, 2026

    Two Swiss Healthcare Startups Raise IPOs Totaling $350M

    Two Swiss-based health-related companies hit U.S. public markets on Friday after pricing initial public offerings that totaled a combined $350 million.

  • November 13, 2026

    5th Circ. Says Asbestos Defense Costs Need Proven Facts

    A Fifth Circuit panel on Friday said excess insurers do not have to cover a drywall company's defense costs for litigation stemming from asbestos exposure in the 1980s, finding a lower court erred in finding defense obligations were triggered by alleged facts rather than established ones.

  • November 13, 2026

    Labcorp Hit With Wage Class Action In Colorado Court

    A former employee of a Labcorp in Denver has hit the company with a wage and hour lawsuit, accusing it of violating city, state and federal wage laws by failing to properly pay overtime, failing to give workers breaks and requiring employees to perform off-the-clock work.

  • November 13, 2026

    Supplement Makers Say FDA Added Illegal Label Review

    A health advocacy group and three dietary supplement sellers urged a D.C. federal judge Friday to rule the U.S. Food and Drug Administration overstepped when it rejected over a hundred label claims for supplement products that connected certain nutrients to health outcomes.

See more Life Sciences news

Life Sciences

Areas of Coverage

  • AGENCIES
  • U.S. Consumer Product Safety Commission
  • U.S. Food and Drug Administration
  • U.S. Patent and Trademark Office
  • U.S. International Trade Commission
  • POLICY & REGULATION
  • Affordable Care Act
  • Federal Food, Drug, and Cosmetic Act
  • Antitrust and consumer protection controls
  • Drug and medical device lobbying
  • State and international life sciences legislation and regulation
  • ENFORCEMENT
  • Drug and medical device recalls
  • Drug safety actions
  • Pay-for-delay investigations
  • Merger reviews
  • LITIGATION
  • Patent disputes, including
  • Abbreviated New Drug Application litigation
  • Section 301 cases
  • Product safety suits over drugs and medical devices, including off-label marketing and failure-to-warn claims
  • Consumer litigation and class actions
  • Fraud and compliance suits
  • Antitrust disputes
  • Labor and employment suits
  • Shareholder and corporate governance disputes
  • Bankruptcy proceedings
  • TRANSACTIONS
  • Mergers, acquisitions, and joint ventures
  • Share buybacks and stock splits
  • Private equity deals
  • Patent-licensing agreements
  • PROFILES
  • Personnel moves
  • Profiles of life sciences practice groups

Readership

  • Life sciences lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Executives and attorneys in the drug, biotechnology, and medical device industries
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals